HAMP

HAMP (Hepcidin Antimicrobial Peptide) is the master conductor of iron metabolism in the human body. Just as insulin manages blood glucose, hepcidin manages blood iron. Because iron is both essential for life (as the core of hemoglobin) and highly toxic in its free state (due to its ability to generate reactive oxygen species), the body must regulate it with extreme precision. Hepcidin is the hormone that performs this balancing act.

The primary role of hepcidin is to act as a "stop" signal for iron entry into the circulation. It does this by targeting ferroportin, the only protein capable of exporting iron out of cells. When hepcidin binds to ferroportin on the surface of gut cells or iron-recycling macrophages, it triggers the destruction of that "exit door." This traps iron inside the cells and prevents it from reaching the bloodstream. Consequently, when iron levels are high, hepcidin rises to shut down further absorption. When iron is low, hepcidin vanishes to open the gates and allow iron to flow into the bone marrow for red blood cell production.

This regulatory system is not only sensitive to iron levels but also to inflammation. During an infection, the body intentionally spikes hepcidin levels. This is a form of "nutritional immunity": by trapping iron inside macrophages, the body hides it from bacteria and fungi that require host iron to multiply. However, in chronic inflammatory states like rheumatoid arthritis or cancer, this same mechanism leads to "anemia of chronic disease," where a patient may have plenty of iron stored in their body, but it is locked away behind hepcidin-closed doors, leaving the red blood cells starving for minerals.

In the context of aging, hepcidin dysregulation is a significant contributor to both systemic anemia and localized iron overload. "Inflammaging," which is the low-grade chronic inflammation common in older adults, leads to inappropriately high hepcidin levels. This not only contributes to the anemia of the elderly but is also linked to iron accumulation in the brain. Dysregulated iron distribution in the central nervous system is a hallmark of several neurodegenerative diseases, making HAMP a target of intense interest in the biology of healthy aging.

The Hepcidin-Ferroportin Handshake

The entire system of systemic iron control rests on a single molecular interaction: the binding of hepcidin to ferroportin.

Molecular Internalization: Hepcidin is a small, 25-amino acid peptide with a unique, rigid structure held together by four disulfide bonds. When it encounters ferroportin on a cell membrane, it binds to it, causing the ferroportin protein to be pulled into the cell (internalized) and moved to the lysosome, where it is broken down. This is an “irreversible” inhibition; to export iron again, the cell must synthesize entirely new ferroportin molecules.

The N-Terminal Key: The first few amino acids of the hepcidin peptide are absolutely critical for this handshake. Mutations or deletions that affect the N-terminus result in a hormone that cannot “talk” to ferroportin, leading to the uncontrolled iron absorption seen in the most severe forms of hereditary hemochromatosis.

Iron-Sensing: The BMP/SMAD Complex

How does the liver know when to secrete hepcidin? It uses a sophisticated protein complex on the surface of hepatocytes that acts as a “molecular rheostat” for iron.

The BMP6 Trigger: When iron levels in the liver rise, sinusoidal cells produce a signaling molecule called BMP6. This binds to a receptor complex on hepatocytes that includes the protein Hemojuvelin (HJV) and the HFE protein (the protein most commonly mutated in hereditary hemochromatosis).

The SMAD Signal: This binding event triggers the SMAD signaling pathway, which moves into the nucleus to turn on the HAMP gene. If any part of this sensing machinery is broken, such as in HFE-related hemochromatosis, the liver “thinks” the body is iron-deficient even when it is overloaded, leading to inappropriately low hepcidin and continued iron absorption.

Nutritional Immunity and the IL-6 Connection

One of the most fascinating aspects of HAMP is its dual role in mineral metabolism and the innate immune response.

The Evolution of a Name: Before its role in iron was understood, hepcidin was discovered as an “antimicrobial peptide” (hence the name HAMP). While its direct killing effect on bacteria is modest compared to other peptides, its role in “starving” bacteria of iron is a masterstroke of evolutionary defense.

STAT3 Activation: During infection, the cytokine IL-6 acts directly on the liver to induce hepcidin via the STAT3 pathway. This happens within hours, causing a rapid drop in serum iron (hypoferremia). This is why a person with an acute infection will often show very low serum iron but high ferritin (stored iron) on a blood test: the hepcidin customs officers have closed the borders to protect the body from the invading pathogen.

Practical Notes for Interpreting Lab Results

Ferritin is a Dual-Marker: In clinical practice, ferritin is used to measure iron stores. However, because hepcidin is induced by inflammation, and ferritin is also an “acute phase reactant,” high ferritin does not always mean high iron. It can also mean “trapped iron” due to high hepcidin.

The Hepcidin-25 Test: Emerging assays for mature hepcidin-25 are becoming the “gold standard” for disambiguating iron status. A high hepcidin level in a patient with anemia points strongly toward inflammation or IRIDA, whereas a low hepcidin level confirms true iron deficiency, guiding whether the patient needs iron supplements or an investigation into the underlying inflammatory cause.